The Mark H Zangmeister Center /ID# 269929 — Columbus, Ohio

The Mark H Zangmeister Center /ID# 269929 is a clinical research site located in Columbus, Ohio, United States 43219.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

The Mark H Zangmeister Center /ID# 269929 has participated in 1 clinical trials.

Therapeutic areas: Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Mark H Zangmeister Center /ID# 269929?

The Mark H Zangmeister Center /ID# 269929 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Mark H Zangmeister Center /ID# 269929 conducted?

The Mark H Zangmeister Center /ID# 269929 has 1 clinical trials on record. Their work covers Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.

Is The Mark H Zangmeister Center /ID# 269929 accredited by Crixeo Health?

The Mark H Zangmeister Center /ID# 269929 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Mark H Zangmeister Center /ID# 269929?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.